Cuba announced this Friday, September 23, 2022, an upcoming clinical trial to test a novel drug developed by a national laboratory for the treatment of alzheimers, disease that is among the main causes of death on the island.
We recommend you: Sea sponges could fight COVID-19 and Alzheimer’s, according to a Mexican study
“In Cuba, a clinical trial will begin in the coming months in all the provinces of the country to test the efficacy and safety” of NeuroEpo in patients with Alzheimer’s disease in the mild-moderate stage, the official said on its website. Ministry of Public Health (MINSAP).
The drug for nasal application has had “good results to treat diseases neurodegenerative“, he added.
He clarified, however, that “there is no effective treatment or proven prevention method for Alzheimer’s disease” and recommended leading a healthy lifestyle.
“In Cuba, dementia is one of the main causes of death and it is the one that requires the most attention and care in older adults,” said the MINSAP.
On the island “there are, at the moment, 160,000 people with dementia,” in a population of 11.2 million inhabitants, he said.
It is estimated that by 2030 this disease “will have a prevalence of 6.4% to 10.8%” among those over 65 years of age.
He pointed out that in 2015, “about 46.8 million people with dementia were estimated in the world, and it will multiply to 65 million by 2030. In Latin America and the Caribbean, it will increase from 3.4 million to 4.1 million by 2030 ”, added the MINSAP.
Cuba faces a rapid aging of its population, one of its main problems due to the migratory exodus that it experiences, especially of young people, who leave due to the severe economic crisis in the country, the worst in the last 30 years.
According to the Statistical Yearbook of Cuba, where life expectancy is 78.89 years, in 2020 21% of the population of some 11 million inhabitants was over 60 years old.
The Minsap considers “important” that the “caregivers” of sick older people are trained by medical personnel, who teach them “the best way to meet the needs of the patient.”
The new Family Code, which will be submitted to a referendum on Sunday, establishes legal rights for these caregivers, which are increasingly necessary in today’s society.
With information from AFP